Value of 18F–FDG PET/CT for predicting EGFR mutations and positive ALK expression in patients with non-small cell lung cancer: a retrospective analysis of 849 Chinese patients
出版年份 2017 全文链接
标题
Value of 18F–FDG PET/CT for predicting EGFR mutations and positive ALK expression in patients with non-small cell lung cancer: a retrospective analysis of 849 Chinese patients
作者
关键词
Epidermal growth factor receptor, Anaplastic lymphoma kinase, Mutation, Non-small cell lung cancer, Positron emission tomography, Standard uptake value
出版物
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Volume 45, Issue 5, Pages 735-750
出版商
Springer Nature
发表日期
2017-11-21
DOI
10.1007/s00259-017-3885-z
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
- (2017) Nasser Hanna et al. JOURNAL OF CLINICAL ONCOLOGY
- Non–Small Cell Lung Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology
- (2017) David S. Ettinger et al. Journal of the National Comprehensive Cancer Network
- Personalizing NSCLC therapy by characterizing tumors using TKI-PET and immuno-PET
- (2017) I. Bahce et al. LUNG CANCER
- The distinct metabolic phenotype of lung squamous cell carcinoma defines selective vulnerability to glycolytic inhibition
- (2017) Justin Goodwin et al. Nature Communications
- Combining PET/CT with serum tumor markers to improve the evaluation of histological type of suspicious lung cancers
- (2017) Rifeng Jiang et al. PLoS One
- Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) S. Novello et al. ANNALS OF ONCOLOGY
- Correlation between EGFR gene mutation, cytologic tumor markers, 18F-FDG uptake in non-small cell lung cancer
- (2016) Arthur Cho et al. BMC CANCER
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Contribution of18Fluorodeoxyglucose positron emission tomography uptake and TTF-1 expression in the evaluation of the EGFR mutation in patients with lung adenocarcinoma
- (2016) Zehra Dilek Kanmaz et al. Cancer Biomarkers
- The asphericity of the metabolic tumour volume in NSCLC: correlation with histopathology and molecular markers
- (2016) Ivayla Apostolova et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Associations Between Somatic Mutations and Metabolic Imaging Phenotypes in Non–Small Cell Lung Cancer
- (2016) Stephen S.F. Yip et al. JOURNAL OF NUCLEAR MEDICINE
- ALK Protein Analysis by IHC Staining after Recent Regulatory Changes: A Comparison of Two Widely Used Approaches, Revision of the Literature, and a New Testing Algorithm
- (2016) Antonio Marchetti et al. Journal of Thoracic Oncology
- Reversal of Warburg Effect and Reactivation of Oxidative Phosphorylation by Differential Inhibition of EGFR Signaling Pathways in Non-Small Cell Lung Cancer
- (2015) V. De Rosa et al. CLINICAL CANCER RESEARCH
- FDG Uptake in Non–Small Cell Lung Cancer Is Not an Independent Predictor of EGFR or KRAS Mutation Status
- (2015) Seok Mo Lee et al. CLINICAL NUCLEAR MEDICINE
- Role of Imaging Biomarkers in Predicting Anaplastic Lymphoma Kinase–Positive Lung Adenocarcinoma
- (2015) Chae Jin Jeong et al. CLINICAL NUCLEAR MEDICINE
- Metabolic Phenotype of Stage IV Lung Adenocarcinoma
- (2015) Elaine Yuen Phin Lee et al. CLINICAL NUCLEAR MEDICINE
- Targeted therapies for treatment of non-small cell lung cancer-Recent advances and future perspectives
- (2015) Joan Minguet et al. INTERNATIONAL JOURNAL OF CANCER
- Signaling through the Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Axis Is Responsible for Aerobic Glycolysis mediated by Glucose Transporter in Epidermal Growth Factor Receptor (EGFR)-mutated Lung Adenocarcinoma
- (2015) Hideki Makinoshima et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- EGFR Mutation Testing Practices within the Asia Pacific Region: Results of a Multicenter Diagnostic Survey
- (2015) Yasushi Yatabe et al. Journal of Thoracic Oncology
- Value of 18F-FDG uptake on PET/CT and CEA level to predict epidermal growth factor receptor mutations in pulmonary adenocarcinoma
- (2014) Kai-Hsiung Ko et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer
- (2014) Carlos Caicedo et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Epidermal Growth Factor Receptor (EGFR) Signaling Regulates Global Metabolic Pathways in EGFR-mutated Lung Adenocarcinoma
- (2014) Hideki Makinoshima et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Molecular Testing for Selection of Patients With Lung Cancer for Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase Tyrosine Kinase Inhibitors: American Society of Clinical Oncology Endorsement of the College of American Pathologists/International Association for the Study of Lung Cancer/Association for Molecular Pathology Guideline
- (2014) Natasha B. Leighl et al. JOURNAL OF CLINICAL ONCOLOGY
- Sample Features Associated with Success Rates in Population-Based EGFR Mutation Testing
- (2014) Carolyn J. Shiau et al. Journal of Thoracic Oncology
- First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
- (2014) Benjamin J. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Histological subtypes of lung cancer in Chinese women from 2000 to 2012
- (2014) Xiao Nong Zou et al. Thoracic Cancer
- Diagnostic value of a novel fully automated immunochemistry assay for detection of ALK rearrangement in primary lung adenocarcinoma
- (2013) J. Ying et al. ANNALS OF ONCOLOGY
- Combined Targeting of PDK1 and EGFR Triggers Regression of Glioblastoma by Reversing the Warburg Effect
- (2013) K. K. Velpula et al. CANCER RESEARCH
- EGFR Mutation-Induced Alternative Splicing of Max Contributes to Growth of Glycolytic Tumors in Brain Cancer
- (2013) Ivan Babic et al. Cell Metabolism
- Novel therapeutic targets in non-small cell lung cancer
- (2013) Muhammad Alamgeer et al. CURRENT OPINION IN PHARMACOLOGY
- Evaluation of 2-Year Experience With EGFR Mutation Analysis of Small Diagnostic Samples
- (2013) Katarina Hlinkova et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- FDG PET/CT metabolic tumor volume and total lesion glycolysis predict prognosis in patients with advanced lung adenocarcinoma
- (2013) Hyun Woo Chung et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors
- (2013) Neal I. Lindeman et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- Crizotinib versus Chemotherapy in Advanced ALK-Positive Lung Cancer
- (2013) Alice T. Shaw et al. NEW ENGLAND JOURNAL OF MEDICINE
- Development of [11C]erlotinib Positron Emission Tomography for In Vivo Evaluation of EGF Receptor Mutational Status
- (2012) I. Bahce et al. CLINICAL CANCER RESEARCH
- First-SIGNAL: First-Line Single-Agent Iressa Versus Gemcitabine and Cisplatin Trial in Never-Smokers With Adenocarcinoma of the Lung
- (2012) Ji-Youn Han et al. JOURNAL OF CLINICAL ONCOLOGY
- Can EGFR-TKIs be used in first line treatment for advanced non-small cell lung cancer based on selection according to clinical factors ? -- A literature-based meta-analysis
- (2012) Chongrui Xu et al. Journal of Hematology & Oncology
- National survey of the medical treatment status for non-small cell lung cancer (NSCLC) in China
- (2012) Cong Xue et al. LUNG CANCER
- Metabolic and metastatic characteristics of ALK-rearranged lung adenocarcinoma on FDG PET/CT
- (2012) Hongyoon Choi et al. LUNG CANCER
- PET imaging of patients with non-small cell lung cancer employing an EGF receptor targeting drug as tracer
- (2011) A A Memon et al. BRITISH JOURNAL OF CANCER
- Establishing an EGFR mutation screening service for non-small cell lung cancer – Sample quality criteria and candidate histological predictors
- (2011) Alexandra F. Leary et al. EUROPEAN JOURNAL OF CANCER
- Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)
- (2011) Masahiro Fukuoka et al. JOURNAL OF CLINICAL ONCOLOGY
- Comparison of clinical outcome of patients with non-small-cell lung cancer harbouring epidermal growth factor receptor exon 19 or exon 21 mutations
- (2011) Y.-W. Won et al. JOURNAL OF CLINICAL PATHOLOGY
- Molecular Imaging with 11C-PD153035 PET/CT Predicts Survival in Non-Small Cell Lung Cancer Treated with EGFR-TKI: A Pilot Study
- (2011) X. Meng et al. JOURNAL OF NUCLEAR MEDICINE
- The challenge of NSCLC diagnosis and predictive analysis on small samples. Practical approach of a working group
- (2011) Erik Thunnissen et al. LUNG CANCER
- Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Predicting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer
- (2011) R. H. Mak et al. ONCOLOGIST
- 18F-FDG uptake and EGFR mutations in patients with non-small cell lung cancer: A single-institution retrospective analysis
- (2009) Im Il Na et al. LUNG CANCER
- Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinoma
- (2009) Chun-Ta Huang et al. MEDICAL ONCOLOGY
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
- (2009) Tony S. Mok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structure and Clinical Relevance of the Epidermal Growth Factor Receptor in Human Cancer
- (2008) Amit Kumar et al. JOURNAL OF CLINICAL ONCOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started